Site US2492 MD Anderson Cancer Ctr — Houston, Texas

Site US2492 MD Anderson Cancer Ctr is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US2492 MD Anderson Cancer Ctr has participated in 1 clinical trials.

Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US2492 MD Anderson Cancer Ctr?

Site US2492 MD Anderson Cancer Ctr has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US2492 MD Anderson Cancer Ctr conducted?

Site US2492 MD Anderson Cancer Ctr has 1 clinical trials on record. Their work covers Metastatic Castration-Resistant Prostate Cancer.

Is Site US2492 MD Anderson Cancer Ctr accredited by Crixeo Health?

Site US2492 MD Anderson Cancer Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US2492 MD Anderson Cancer Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.